4Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science, 1994,266:2011-2015.
5Cong YS, Wen JP, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Human Molecular Genetics,1999,8:137-142.
6Emrich T,Karl G,Panzinger B.Detection of telomerase components by quantitative real-time on-line PCR analysis with the LightCycler.Biochemica,2000,4:16-19.
7Shay JW,Zou Y,Hiyama E,et al.Telomerase and cancer. Human Molecular Genetics,2001,10:677-685.
8Kirkpatrick KL,Mokbel K.The significance of human telomerase reverse transcriptase (hTERT) in cancer.Eur J Surg Oncol,2001,27:754-760.
4Morita K, Okabe I, Uchino J, et al. The proposed Japanese TNM classification of primary liver carcinoma in infants and children. Jpn J Clin Oncol, 1983, 13:361-369.
5von Schweinitz D, Burger D, Mildenberger H. Is laparatomy the first step in treatment of childhood liver tumors? The experience from the German Cooperative Pediatric Liver Tumor Study HB- 89. EurJ Pediatr Surg, 1994, 4:82-86.
6von Schweinitz D, Hecker H, Schmidt-von-Arndt G, et al. Prognostic factors and staging systems in childhood hepatoblastoma. Int J Cancer, 1997,74:593-599.
7Aronson DC, Schnater JM, Staalman CR, et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the international society of pediatric oncology liver tumer study group SIOPEL-1 Study. J Clin Oncol, 2005, 23:1245-1252.
8Czauderna P, Otte JB, Aronson DC, et al. Guidelines for surgical treatment of hepatoblastoma in the modern era-recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oneology (SIOPEL). Eur J Cancer, 2005, 41:1031-1036.
9Perilongo G, Shafford E, Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol, 2000, 1: 94-100.
10Perilongo G, Shafford E, Maibach R, et al. Risk-adapted treatment for childhood hepatoblastoma., final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. EurJ Cancer, 2004, 40: 411-421.
